Polyethylene glycosylated (PEG)-asparaginase is a cornerstone of treatment for acute lymphoblastic leukemia (ALL), and effective administration is associated with better outcomes. PEG-asparaginase is associated with a uniphasic hypersensitivity reaction in ∼10% to 20% of patients. We present a 17-year-old male individual diagnosed with very high-risk pre-B-ALL, who experienced protracted anaphylaxis 1 hour following administration of his second PEG-asparaginase dose. This type of allergic reaction has yet to be described in ALL patients treated with PEG-asparaginase. Here, we outline the time course and successful management of protracted anaphylaxis in an ALL patient.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000001906DOI Listing

Publication Analysis

Top Keywords

protracted anaphylaxis
12
time course
8
management protracted
8
peg-asparaginase
5
course management
4
anaphylaxis peg-asparaginase
4
peg-asparaginase polyethylene
4
polyethylene glycosylated
4
glycosylated peg-asparaginase
4
peg-asparaginase cornerstone
4

Similar Publications

Protracted anaphylaxis and cytokine release syndrome 6 days after rituximab desensitization.

Ann Allergy Asthma Immunol

July 2024

Division of Allergy and Immunology, Department of Medicine, Henry Ford Health, Detroit, Michigan; Department of Medicine, Wayne State University, Detroit, Michigan; Department of Medicine, Michigan State University, East Lansing, Michigan. Electronic address:

View Article and Find Full Text PDF

Sugammadex-Induced Anaphylactic Shock Reversed With Short-Term Continuous Veno-Venous Hemodiafiltration: A Case Report.

A A Pract

November 2023

From the Department of Anesthesiology, Intensive Care and Pain Medicine, Meir Medical Center, Kfar Saba, Israel, affiliated with the Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Anaphylaxis is a life-threatening, systemic, hypersensitivity reaction, manifested by urticaria, hypotension, and respiratory symptoms. Antigens that are cleared renally may have protracted exposure in patients with impaired renal function, resulting in prolonged and refractory anaphylactic shock. After administration of sugammadex, a 47-year-old man developed prolonged, refractory anaphylactic shock, with anuria due to acute kidney injury.

View Article and Find Full Text PDF

Alpha-gal Syndrome - A Case Report of Tick-Borne Anaphylactic Shock.

Eur J Case Rep Intern Med

June 2023

Department of Internal Medicine, Faculty of Medicine in Pilsen, Pilsen University Hospital, Pilsen, Czech Republic.

Unlabelled: The most common cause of vasoplegic shock in critical care is sepsis. However, although rarely and only in specifically sensitised individuals previously bitten by a tick, red meat may provoke a delayed allergic reaction called an alpha-gal syndrome. We present a case of a protracted life-threatening manifestation of alpha-gal syndrome, which, due to an unusual absence of typical features of anaphylaxis can masquerade as septic shock and calls attention to the premature diagnostic closure as a contributor to diagnostic error.

View Article and Find Full Text PDF

Anaphylaxis:: After the Emergency Department.

Immunol Allergy Clin North Am

August 2023

Ochsner Medical Center, 1514 Jefferson Hwy, New Orleans, LA 70121, USA. Electronic address:

After treating the acute anaphylactic reaction, the clinician's next task is to prevent a recurrence. The patient should be observed in the ED. How long this observation period should last depends on their clinical course, risk factors, and social support.

View Article and Find Full Text PDF

Tryptase in type I hypersensitivity.

Ann Allergy Asthma Immunol

February 2023

Microbes, Evolution, Phylogénie et Infection (MEPHI), Aix-Marseille University, Marseille, France; Institut Hospitalo-Universitaire (IHU) Méditerranée Infection, Marseille, France; Montpellier University, Institut Desbrest d'Épidémiologie et de Santé Publique, Institut National de la Sante et de la Recherche Medicale, UMR UA 11, Montpellier, France. Electronic address:

Tryptase is currently the main mast cell biomarker available in medical practice. Tryptase determination is a quantitative test performed in serum or plasma for the diagnosis, stratification, and follow-up of mast cell-related conditions. The continuous secretion of monomeric α and β protryptases forms the baseline tryptase level.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!